Repinotan Bayer

Research output: Contribution to journalArticle

13 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)924-927
Number of pages4
JournalCurrent Opinion in Investigational Drugs
Volume3
Issue number6
StatePublished - Jun 1 2002

Fingerprint

Serotonin 5-HT1 Receptors
Benzopyrans
Thiazoles
Serotonin Receptor Agonists
Phase III Clinical Trials
Phase II Clinical Trials
Clinical Trials, Phase I
Preclinical Drug Evaluations
Serotonin Receptors
Lethal Dose 50
Structure-Activity Relationship
Brain Injuries
Stroke

ASJC Scopus subject areas

  • Pharmacology

Cite this

Repinotan Bayer. / Lutsep, Helmi.

In: Current Opinion in Investigational Drugs, Vol. 3, No. 6, 01.06.2002, p. 924-927.

Research output: Contribution to journalArticle

Lutsep, Helmi. / Repinotan Bayer. In: Current Opinion in Investigational Drugs. 2002 ; Vol. 3, No. 6. pp. 924-927.
@article{6dd7a699d88f4059a1e75ff5d0e63e3a,
title = "Repinotan Bayer",
author = "Helmi Lutsep",
year = "2002",
month = "6",
day = "1",
language = "English (US)",
volume = "3",
pages = "924--927",
journal = "Current Opinion in Investigational Drugs",
issn = "1354-3784",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Repinotan Bayer

AU - Lutsep, Helmi

PY - 2002/6/1

Y1 - 2002/6/1

UR - http://www.scopus.com/inward/record.url?scp=0036628456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036628456&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 924

EP - 927

JO - Current Opinion in Investigational Drugs

JF - Current Opinion in Investigational Drugs

SN - 1354-3784

IS - 6

ER -